MX2014003051A - Composiciones para el tratamiento de ulceras perifericas de diversos origenes. - Google Patents

Composiciones para el tratamiento de ulceras perifericas de diversos origenes.

Info

Publication number
MX2014003051A
MX2014003051A MX2014003051A MX2014003051A MX2014003051A MX 2014003051 A MX2014003051 A MX 2014003051A MX 2014003051 A MX2014003051 A MX 2014003051A MX 2014003051 A MX2014003051 A MX 2014003051A MX 2014003051 A MX2014003051 A MX 2014003051A
Authority
MX
Mexico
Prior art keywords
treatment
ulcers
various origins
compositions
combinations
Prior art date
Application number
MX2014003051A
Other languages
English (en)
Other versions
MX347245B (es
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of MX2014003051A publication Critical patent/MX2014003051A/es
Publication of MX347245B publication Critical patent/MX347245B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a combinaciones de un agente que estimula la proliferación celular y un anti-inflamatorio/analgésic o, que resultan útiles para el tratamiento de úlceras periféricas de diversos orígenes, tales como dermatitis por radiación, úlceras diabéticas, úlceras causadas por éxtasis venosa de los miembros, escaras, y las infecciones cutáneas que se les asocian, proctitis, vulvovaginitis y hemorroides con lesiones vasculares; estas combinaciones se pueden presentar como formulaciones para uso tópico.
MX2014003051A 2011-09-16 2012-09-13 Composiciones para el tratamiento de úlceras periféricas de diversos orígenes. MX347245B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001671A ITMI20111671A1 (it) 2011-09-16 2011-09-16 Composizioni per il trattamento di ulcere periferiche di varia origine
PCT/EP2012/067893 WO2013037859A1 (en) 2011-09-16 2012-09-13 Compositions for the treatment of peripheral ulcers of various origins

Publications (2)

Publication Number Publication Date
MX2014003051A true MX2014003051A (es) 2014-04-10
MX347245B MX347245B (es) 2017-04-19

Family

ID=44907960

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003051A MX347245B (es) 2011-09-16 2012-09-13 Composiciones para el tratamiento de úlceras periféricas de diversos orígenes.

Country Status (21)

Country Link
US (3) US9278084B2 (es)
EP (1) EP2755670B1 (es)
JP (1) JP6026540B2 (es)
KR (1) KR101996319B1 (es)
CN (1) CN103874499B9 (es)
AR (1) AR087879A1 (es)
AU (1) AU2012307406B2 (es)
BR (1) BR112014005966A2 (es)
CA (1) CA2848570C (es)
DK (1) DK2755670T3 (es)
ES (1) ES2577405T3 (es)
HU (1) HUE028120T2 (es)
IL (1) IL231498B (es)
IT (1) ITMI20111671A1 (es)
MX (1) MX347245B (es)
PL (1) PL2755670T3 (es)
PT (1) PT2755670E (es)
RU (1) RU2619853C2 (es)
SG (1) SG11201400617UA (es)
SI (1) SI2755670T1 (es)
WO (1) WO2013037859A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105531282A (zh) * 2013-07-14 2016-04-27 阿西罗斯股份有限公司 治疗与线粒体功能或抑制PDE4、PDE5和IKK-β相关的病况的源自茶藨子属物种的生物碱组合物
CN103961482A (zh) * 2014-04-23 2014-08-06 湖州康企药业有限公司 一种治疗皮炎的天然药物
ITUB20160672A1 (it) * 2016-02-11 2017-08-11 Mireno Leoni Composizione farmaceutica per il trattamento della disidrosi
KR101892865B1 (ko) 2017-08-16 2018-08-28 계명대학교 산학협력단 마퀴베리를 유효성분으로 함유하는 아토피성 피부염 예방 또는 치료용 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1589294A (en) * 1976-09-08 1981-05-13 Inverni Della Beffa Spa Pharmaceutical compositions containing anthocyanidines
US4376781A (en) * 1978-02-27 1983-03-15 Inverni Della Beffa S.P.A. Pharmaceutical compositions
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
IT1231725B (it) * 1989-08-11 1991-12-21 Inverni Della Beffa Spa Procedimento per la preparazione di estratti ad alto contenuto in antocianosidi.
EP0464298B1 (en) * 1990-07-05 1995-06-21 INDENA S.p.A. Echinacea extracts, a process for the preparation thereof and formulations containing them
IT1255029B (it) * 1992-05-11 1995-10-13 Paolo Morazzoni Formulazioni farmaceutiche orali contenenti antocianosidi
IT1270602B (it) * 1994-07-12 1997-05-07 Indena Spa Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico
US6224871B1 (en) * 1998-03-11 2001-05-01 Reliv International, Inc. Dietary supplement for nutritionally promoting healthy joint function
ES2266251T3 (es) * 2000-08-31 2007-03-01 Phenolics, Llc Metodo eficaz para producir composiciones enriquecidas con antocianinas.
NZ515182A (en) * 2001-10-31 2004-03-26 Brightwater Horticulture Ltd Extraction of biologically active compounds from plant material using acid and antioxidant
US20030152610A1 (en) * 2002-01-28 2003-08-14 David Rolf Cosmetic patch
US8337914B2 (en) * 2002-02-27 2012-12-25 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
RU2203082C1 (ru) * 2002-07-22 2003-04-27 Государственное учреждение Тверская государственная медицинская академия Способ лечения язвенно-эрозивных поражений гастродуоденальной зоны в сочетании с артериальной гипертензией
ITMI20032287A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie
ITMI20042414A1 (it) * 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
TWI286941B (en) * 2005-07-27 2007-09-21 Anagen Therapeutics Inc Stabilized pharmaceutical and cosmetic composition of catechins or derivatives thereof
GB2428952B (en) 2005-07-30 2010-10-06 Hewlett Packard Development Co Digital pen and paper system
US7763289B2 (en) * 2005-09-01 2010-07-27 JoAl's Products, LLC Topical turmeric skin care products
US7303772B2 (en) * 2005-11-10 2007-12-04 Olalde Rangel Jose Angel Synergistic phytoceutical compositions
EP1882473A1 (en) * 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs
JP5707655B2 (ja) * 2008-07-22 2015-04-30 イズン ファーマシューティカルズ, インコーポレイテッド 局所的抗炎症配合剤

Also Published As

Publication number Publication date
AR087879A1 (es) 2014-04-23
CN103874499B (zh) 2018-07-27
HUE028120T2 (en) 2016-11-28
CA2848570C (en) 2020-12-22
DK2755670T3 (en) 2016-08-15
PL2755670T3 (pl) 2016-11-30
JP2014526487A (ja) 2014-10-06
US20160058812A1 (en) 2016-03-03
RU2619853C2 (ru) 2017-05-18
KR101996319B1 (ko) 2019-07-04
EP2755670A1 (en) 2014-07-23
SI2755670T1 (sl) 2016-07-29
IL231498B (en) 2018-01-31
US20170035826A1 (en) 2017-02-09
AU2012307406A1 (en) 2014-04-03
PT2755670E (pt) 2016-06-20
ES2577405T3 (es) 2016-07-14
JP6026540B2 (ja) 2016-11-16
ITMI20111671A1 (it) 2013-03-17
SG11201400617UA (en) 2014-05-29
CN103874499A (zh) 2014-06-18
MX347245B (es) 2017-04-19
EP2755670B1 (en) 2016-05-11
CA2848570A1 (en) 2013-03-21
RU2014109796A (ru) 2015-09-20
CN103874499B9 (zh) 2018-09-21
US9278084B2 (en) 2016-03-08
KR20140067045A (ko) 2014-06-03
AU2012307406B2 (en) 2016-11-17
IL231498A0 (en) 2014-04-30
US10149877B2 (en) 2018-12-11
US9526716B2 (en) 2016-12-27
BR112014005966A2 (pt) 2017-04-04
US20140220165A1 (en) 2014-08-07
WO2013037859A1 (en) 2013-03-21

Similar Documents

Publication Publication Date Title
MY164356A (en) Substituted 5-fluoro-1h-pyrazolopyridines and their use
EP4249001A3 (en) Topical gels
GT201500051A (es) Inhibidores de glucosilceramida sintasa
TN2013000310A1 (en) Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
MX341300B (es) Composiciones para el tratamiento de ulceras perifericas de varios origenes.
MY181602A (en) Isochromene derivatives as phosphoinositide 3-kinases inhibitors
MX2015003021A (es) Derivados de acido glicirretinico y metodos de uso de los mismos.
MX2013003635A (es) Compuestos de n-heteroarilo.
MX2012006320A (es) Composiciones de amantadina y metodos para su uso.
CO6710913A2 (es) Uso de ácido lipasa lisosomal para tratar la deficiencia de ácido lipasa lisosomal en pacientes
NZ716034A (en) Treatment of inflammatory lesions of rosacea with ivermectin
IN2014DN06104A (es)
PH12014502079A1 (en) Vesicular formulations for use in the treatment of pain or reduced mobility of a joint
IN2014KN02914A (es)
MX347245B (es) Composiciones para el tratamiento de úlceras periféricas de diversos orígenes.
IN2014DN00123A (es)
PH12015500822A1 (en) Treatment of hyperproliferative and pre-cancerous skin diseases using an inhibitor of cbp/catenin
WO2012044963A3 (en) Perfluorocarbons for use in treating pruritus
MX2014010749A (es) Composicion ginecologica para tratar la vestibulitis vulvar.
EA201491836A1 (ru) Способы лечения рака с использованием ингибитора pi3k и ингибитора mek
MX342979B (es) Uso de fotoliasa para la reduccion o mejora del campo de cancerizacion subclinico asociado a la queratosis actinica.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
WO2011159254A3 (en) The use of des-aspartate-angiotensin i in inflammation-related pathologies and diseases
UA112059C2 (uk) Комбінована терапія із кріохірургією і іміквімодом для лікування актинічного кератозу (варіанти)
NZ629711A (en) Anti-inflammatory compositions, methods and uses thereof

Legal Events

Date Code Title Description
FG Grant or registration